Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Won, Ki Bum ^a   Chang, Hyuk Jae ^b   Kim, Hyeon Chang ^b   Jeon, Kyewon ^b   Lee, Hancheol ^b   Shin, Sanghoon ^b   Cho, In Jeong ^b   Park, Sung Ha ^b   Lee, Sang Hak ^b   Jang, Yangsoo ^b  

^a Kwandong University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Atherosclerosis; Diabetes; Metabolic syndrome

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT;

ABDOMINAL OBESITY; ADULT; AGED; ANKLE BRACHIAL INDEX; ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BRACHIAL ANKLE PULSE WAVE VELOCITY; CAROTID ATHEROSCLEROSIS; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PULSE WAVE; RISK FACTOR; SUBCLINICAL ATHEROSCLEROSIS;

AGED; ATHEROSCLEROSIS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84874435007     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-41     Document Type: Article

References (30)

1. NCEP Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Assoc 2001, 285:2486-2497. NCEP.
2. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 2005, 112:2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. J Am Med Assoc 2002, 287:356-359.
4. Park JS, Park HD, Yun JW, Jung CH, Lee WY, Kim SW. Prevalence of the metabolic syndrome as defined by NCEP-ATPIII among the urban Korean population. Korean J Med 2002, 63:290-298.
5. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver Dam. Diabetes Care 2002, 25:1790-1794. 10.2337/diacare.25.10.1790, 12351479.
6. Nakanishi N, Takatorige T, Fukuda H, Shirai K, Li W, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract 2004, 64:59-70. 10.1016/j.diabres.2003.10.001, 15036828.
7. Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajkovich Mirchov I, Ben-Nakhi A, Reaven G, Hama Sambo B, Mendis S, Roglic G. The metabolic syndrome: useful concept or clinical tool? report of a WHO expert consultation. Diabetologia 2010, 53:600-605. 10.1007/s00125-009-1620-4, 20012011.
8. Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, Yamamoto Y, Hori S. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003, 26:615-622. 10.1291/hypres.26.615, 14567500.
9. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998, 128:262-269.
10. Roman MJ, Naqvi TZ, Gardin JM, Gerhard-Herman M, Jaff M, Mohler E. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American society of echocardiography and the society of vascular medicine and biology. J Am Soc Echocardiogr 2006, 19:943-954. 10.1016/j.echo.2006.04.020, 16880089.
11. Hunt KJ, Sharrett AR, Chambless LE, Folsom AR, Evans GW, Heiss G. Acoustic shadowing on B-mode ultrasound of the carotid artery predicts CHD. Ultrasound Med Biol 2001, 27:357-365. 10.1016/S0301-5629(00)00353-7, 11369121.
12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 260(Suppl 1):S5-S20. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
13. Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ, Lakatta EG. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 2004, 43:1388-1395. 10.1016/j.jacc.2003.10.061, 15093872.
14. Nakanishi N, Suzuki K, Tatara K. Clustered features of the metabolic syndrome and the risk for increased aortic pulse wave velocity in middle-aged Japanese men. Angiology 2003, 54:551-559. 10.1177/000331970305400504, 14565630.
15. Larsen JR, Brekke M, Bergengen L, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K. Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes. Diabetologia 2005, 48:776-779. 10.1007/s00125-005-1700-z, 15759107.
16. Sander D, Schulze-Horn C, Bickel H, Gnahn H, Bartels E, Conrad B. Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. Stroke 2006, 37:351-357. 10.1161/01.STR.0000199034.26345.bc, 16373634.
17. Czernichow S, Bertrais S, Blacher J, Oppert JM, Galan P, Ducimetière P, Hercberg S, Safar M, Zureik M. Metabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure. A report from the SU.VI.MAX. Vascular study. Am J Hypertens 2005, 18:1154-1160. 10.1016/j.amjhyper.2005.04.006, 16182103.
18. Gupta AK, Prieto-Merino D, Dahlöf B, Sever PS, Poulter NR. Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach. Diabet Med 2011, 28:941-947. 10.1111/j.1464-5491.2011.03330.x, 21749444.
19. Stern MP, Williams K, González-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diabetes Care 2004, 27:2676-2681. 10.2337/diacare.27.11.2676, 15505004.
20. Koehler C, Ott P, Benke I, Hanefeld M. Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: the diabetes in Germany (DIG) study. Horm Metab Res 2007, 39:632-635. 10.1055/s-2007-985816, 17846969.
21. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003, 52:1210-1214. 10.2337/diabetes.52.5.1210, 12716754.
22. Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, Ozaki R, Chow CC, Lam CW, Chan JC, Cockram CS. The usefulness of the international diabetes federation and the national cholesterol education Program's adult treatment panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007, 30:1206-1211. 10.2337/dc06-1484, 17259472.
23. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in united states adults. Circulation 2004, 110:1245-1250. 10.1161/01.CIR.0000140677.20606.0E, 15326067.
24. Church TS, Thompson AM, Katzmarzyk PT, Sui X, Johannsen N, Earnest CP, Blair SN. Metabolic syndrome and diabetes, alone and in combination, as predictors of cardiovascular disease mortality among men. Diabetes Care 2009, 32:1289-1294. 10.2337/dc08-1871, 2699717, 19366967.
25. Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? systematic review and metaanalysis. Diabet Med 2009, 26:142-148. 10.1111/j.1464-5491.2008.02640.x, 19236616.
26. Malik S, Budoff MJ, Katz R, Blumenthal RS, Bertoni AG, Nasir K, Szklo M, Barr RG, Wong ND. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Diabetes Care 2011, 34:2285-2290. 10.2337/dc11-0816, 3177707, 21844289.
27. Wong ND, Nelson JC, Granston T, Bertoni AG, Blumenthal RS, Carr JJ, Guerci A, Jacobs DR, Kronmal R, Liu K, Saad M, Selvin E, Tracy R, Detrano R. Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the multiethnic study of atherosclerosis study. JACC Cardiovasc Imaging 2012, 5:358-366. 10.1016/j.jcmg.2011.12.015, 22498324.
28. Gurka MJ, Ice CL, Sun SS, Deboer MD. A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences. Cardiovasc Diabetol 2012, 11:128. 10.1186/1475-2840-11-128, 3489601, 23062212.
29. Herder M, Arntzen KA, Johnsen SH, Mathiesen EB. The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The tromsø study. Cardiovasc Diabetol 2012, 11:77. 10.1186/1475-2840-11-77, 3539868, 22738646.
30. Pattyn N, Cornelissen VA, Eshghi SR, Vanhees L. The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome: a meta-analysis of controlled trials. Sports Med 2013, 43:121-133. 10.1007/s40279-012-0003-z, 23329606.